CLEAR CELL RENAL CELL CARCINOMA
Clinical trials for CLEAR CELL RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for CLEAR CELL RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to boost immune system against advanced kidney cancer before surgery
Disease control TerminatedThis study tested whether giving a drug called pembrolizumab, with or without another drug called axitinib, before and after surgery could help people with advanced kidney cancer. The goal was to see if this approach could better control the cancer and reduce the chance of it com…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New pill tested for Tough-to-Treat kidney cancer
Disease control TerminatedThis study tested a new oral pill called NKT2152 for adults with advanced kidney cancer that had stopped responding to standard treatments. The first part aimed to find a safe and effective dose. The second part planned to see how well the pill could shrink tumors and control the…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
First human test of experimental cancer drug halted early
Disease control TerminatedThis was an early-stage study testing a new drug called BDC-3042, both by itself and combined with an existing immunotherapy (cemiplimab), in people with advanced cancers that had stopped responding to standard treatments. The main goals were to find safe doses and see if the tre…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Bolt Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Two-Pronged attack tested for tough cancers
Disease control TerminatedThis study tested whether combining two drugs, niraparib and dostarlimab, could help control advanced cancers that had specific genetic problems or were previously sensitive to platinum chemotherapy. It involved 51 adults with various cancers, including bladder, stomach, and kidn…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Terminated trial tests Last-Chance drugs for tough kidney cancers
Disease control TerminatedThis study tested two different drug combinations for people with advanced kidney cancer that had stopped responding to standard treatments. The trial aimed to find safe doses and see if these combinations could shrink tumors or slow disease progression. The study was terminated …
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC